Blood clot prevention after colorectal cancer surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer and are scheduled for surgery lasting at least 45 minutes.
- Your doctor expects you to live more than 6 months after surgery.
- You do not have a bleeding disorder, active bleeding, or a recent blood clot.
- You have not taken blood-thinning medicines in the 5 days before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood-thinning drug to prevent dangerous blood clots (venous thromboembolism) in people with colorectal cancer who are having surgery. It aims to see if the drug can help reduce clot risk safely.
This study looks at when to start blood thinners after surgery for colorectal cancer. The goal is to find the safest time to prevent blood clots without increasing bleeding risk.
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Hear when a new Colorectal Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.